AICARM NEWS – November 2025
This month, AICARM on aicarm news. Let's help reduce the waiting list times of the national health system, we talk about youth hardship and gliflozins.
This month, AICARM on aicarm news. Let's help reduce the waiting list times of the national health system, we talk about youth hardship and gliflozins.
An AICARM webinar for those living with cardiomyopathy who want to understand how to improve their quality and length of life. With experts in cardiogeriatrics and longevity, we'll explore how the heart changes with age, which lifestyles promote active aging, and which clinical strategies can truly make a difference. A practical, up-to-date session designed for patients and families, with time for questions and answers.
Valerio Pelini was born in Figline Valdarno on May 14, 1951, and still lives there. Currently retired, he is a founding member of Aicarm Onlus and has served on the Board of Directors since its inception. He also volunteers extensively for other organizations. He holds a degree in literature, specializing in history, and served as Director General of the Tuscany Region from 1996 to 2009 and from 2010 to [...]
Family Burdens and Prejudice: Protecting Women's Hearts The AICARM APS conference. Doctors, patients, researchers, and women social workers gathered in Florence on Saturday, November 8th at the Istituto degli Innocenti to discuss a still largely overlooked topic: women's heart health. The conference, titled "Women's Hearts – Diversity in Cardiomyopathies," was a collaboration between AICARM APS and [...]
Gliflozins, initially developed as diabetes drugs, have proven to be one of the greatest revolutions in heart failure treatment. Thanks to robust clinical trials, they have become the fourth pillar of therapy and are also showing benefits for the kidneys and, perhaps, even cardiac protection in oncology. A clear and up-to-date analysis of what patients and families need to know.
The "Parents, Adolescents, and Cardiomyopathy" project, developed by AICARM with the University of Pisa, supports the emotional well-being of parents of young people diagnosed with cardiomyopathy. A research program and dedicated support groups address fears, daily challenges, and new ways of relating to their children.
Waiting lists for cardiology appointments and tests are a serious problem for people with cardiomyopathy. AICARM is launching a national collection of reports to document real difficulties, give patients a voice, and call on institutions to take concrete action to improve access to care.
AICARM addresses the problem of waiting lists in the National Health System with a new survey dedicated to patients with cardiomyopathy. The newsletter also features the project dedicated to young people and families, the gliflozin revolution, and the report of the conference "The Heart of Women."
Atrial fibrillation is the most common heart rhythm disorder, but also one of the most insidious for those living with cardiomyopathy. It often appears silently, but it can increase the risk of heart failure and serious complications such as stroke. Sign up for the webinar at aicarm.it
The second edition of the Masterclass on Hypertrophic Obstructive Cardiomyopathy will be held in Florence from November 11 to 13, 2025. The event, sponsored by AICARM APS and organized by Professor Iacopo Olivotto, will bring together national and international experts to delve deeper into diagnosis, genetics, imaging, and new therapeutic strategies.